{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:34:04Z","timestamp":1793363644311,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":1188,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1124\/molpharm.121.000297","type":"journal-article","created":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T18:25:22Z","timestamp":1627323922000},"page":"309-318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Eribulin Activates the cGAS-STING Pathway via the Cytoplasmic Accumulation of Mitochondrial DNA"],"prefix":"10.1016","volume":"100","author":[{"given":"Charles S.","family":"Fermaintt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Takahashi-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyun","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L.","family":"Mooberry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April L.","family":"Risinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/molpharm.121.000297_bib1","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.taap.2003.12.001","article-title":"The effects of ethidium bromide induced loss of mitochondrial DNA on mitochondrial phenotype and ultrastructure in a human leukemia T-cell line (MOLT-4 cells)","volume":"196","author":"Armand","year":"2004","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/molpharm.121.000297_bib2","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1158\/1535-7163.MCT-12-1197","article-title":"Vinblastine rapidly induces NOXA and acutely sensitizes primary chronic lymphocytic leukemia cells to ABT-737","volume":"12","author":"Bates","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"10.1124\/molpharm.121.000297_bib3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/bcp.13126","article-title":"Microtubule destabilising agents: far more than just antimitotic anticancer drugs","volume":"83","author":"Bates","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/molpharm.121.000297_bib4","doi-asserted-by":"crossref","first-page":"13681","DOI":"10.1073\/pnas.251194298","article-title":"SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase","volume":"98","author":"Bennett","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/molpharm.121.000297_bib5","doi-asserted-by":"crossref","first-page":"33664","DOI":"10.1074\/jbc.M203834200","article-title":"Tubulin is an inherent component of mitochondrial membranes that interacts with the voltage-dependent anion channel","volume":"277","author":"Carr\u00e9","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1124\/molpharm.121.000297_bib6","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1158\/2326-6066.CIR-13-0123","article-title":"STING ligand c-di-GMP improves cancer vaccination against metastatic breast cancer","volume":"2","author":"Chandra","year":"2014","journal-title":"Cancer Immunol Res"},{"key":"10.1124\/molpharm.121.000297_bib7","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.120638","article-title":"A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1-insensitive models of triple-negative breast cancer","volume":"3","author":"Cheng","year":"2018","journal-title":"JCI Insight"},{"key":"10.1124\/molpharm.121.000297_bib8","doi-asserted-by":"crossref","first-page":"14136","DOI":"10.1074\/jbc.M109.000414","article-title":"Use of the pharmacological inhibitor BX795 to study the regulation and physiological roles of TBK1 and IkappaB kinase \u03f5: a distinct upstream kinase mediates Ser-172 phosphorylation and activation","volume":"284","author":"Clark","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1124\/molpharm.121.000297_bib9","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/nrd3253","article-title":"Microtubule-binding agents: a dynamic field of cancer therapeutics","volume":"9","author":"Dumontet","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/molpharm.121.000297_bib10","doi-asserted-by":"crossref","first-page":"5545","DOI":"10.18632\/oncotarget.23798","article-title":"Regulation of E-cadherin localization by microtubule targeting agents: rapid promotion of cortical E-cadherin through p130Cas\/Src inhibition by eribulin","volume":"9","author":"Dybdal-Hargreaves","year":"2017","journal-title":"Oncotarget"},{"key":"10.1124\/molpharm.121.000297_bib11","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1016\/j.bmc.2014.02.035","article-title":"Microtubule-targeting agents are clinically successful due to both mitotic and interphase impairment of microtubule function","volume":"22","author":"Field","year":"2014","journal-title":"Bioorg Med Chem"},{"key":"10.1124\/molpharm.121.000297_bib12","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3390\/ijms20030586","article-title":"The potential of combining tubulin-targeting anticancer therapeutics and immune therapy","volume":"20","author":"Fong","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1124\/molpharm.121.000297_bib13","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.tcb.2018.02.010","article-title":"BAX and BAK at the gates of innate immunity","volume":"28","author":"Galluzzi","year":"2018","journal-title":"Trends Cell Biol"},{"key":"10.1124\/molpharm.121.000297_bib14","doi-asserted-by":"crossref","first-page":"17118","DOI":"10.1074\/jbc.272.27.17118","article-title":"Paclitaxel-resistant human ovarian cancer cells have mutant \u03b2-tubulins that exhibit impaired paclitaxel-driven polymerization","volume":"272","author":"Giannakakou","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1124\/molpharm.121.000297_bib15","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1158\/1078-0432.CCR-08-2429","article-title":"A phase I study of eribulin mesylate (E7389), a mechanistically novel inhibitor of microtubule dynamics, in patients with advanced solid malignancies","volume":"15","author":"Goel","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1124\/molpharm.121.000297_bib16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41586-018-0287-8","article-title":"Targeting STING with covalent small-molecule inhibitors","volume":"559","author":"Haag","year":"2018","journal-title":"Nature"},{"key":"10.1124\/molpharm.121.000297_bib17","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nature23470","article-title":"Mitotic progression following DNA damage enables pattern recognition within micronuclei","volume":"548","author":"Harding","year":"2017","journal-title":"Nature"},{"key":"10.1124\/molpharm.121.000297_bib18","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.immuni.2015.01.012","article-title":"DNA damage primes the type I interferon system via the cytosolic DNA sensor STING to promote anti-microbial innate immunity","volume":"42","author":"H\u00e4rtlova","year":"2015","journal-title":"Immunity"},{"key":"10.1124\/molpharm.121.000297_bib19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/ni.2475","article-title":"Trex1 regulates lysosomal biogenesis and interferon-independent activation of antiviral genes","volume":"14","author":"Hasan","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1124\/molpharm.121.000297_bib20","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.immuni.2006.08.009","article-title":"Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors","volume":"25","author":"Honda","year":"2006","journal-title":"Immunity"},{"key":"10.1124\/molpharm.121.000297_bib21","doi-asserted-by":"crossref","DOI":"10.1172\/JCI139333","article-title":"ATM inhibition enhances cancer immunotherapy by promoting mtDNA leakage and cGAS\/STING activation","volume":"131","author":"Hu","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1124\/molpharm.121.000297_bib22","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/oxfordjournals.annonc.a059287","article-title":"Pharmacokinetics of paclitaxel and three major metabolites in patients with advanced breast carcinoma refractory to anthracycline therapy treated with a 3-hour paclitaxel infusion: a European Cancer Centre (ECC) trial","volume":"6","author":"Huizing","year":"1995","journal-title":"Ann Oncol"},{"key":"10.1124\/molpharm.121.000297_bib23","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1242\/jcs.114.2.281","article-title":"Opposite effects of microtubule-stabilizing and microtubule-destabilizing drugs on biogenesis of mitochondria in mammalian cells","volume":"114","author":"Karbowski","year":"2001","journal-title":"J Cell Sci"},{"key":"10.1124\/molpharm.121.000297_bib24","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41416-019-0556-9","article-title":"Eribulin rapidly inhibits TGF-\u03b2-induced Snail expression and can induce Slug expression in a Smad4-dependent manner","volume":"121","author":"Kaul","year":"2019","journal-title":"Br J Cancer"},{"key":"10.1124\/molpharm.121.000297_bib25","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1021\/acs.jnatprod.9b00105","article-title":"Microtubule-targeting drugs: more than antimitotics","volume":"82","author":"Kaul","year":"2019","journal-title":"J Nat Prod"},{"key":"10.1124\/molpharm.121.000297_bib26","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1126\/science.aav4011","article-title":"VDAC oligomers form mitochondrial pores to release mtDNA fragments and promote lupus-like disease","volume":"366","author":"Kim","year":"2019","journal-title":"Science"},{"key":"10.1124\/molpharm.121.000297_bib27","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nrclinonc.2010.228","article-title":"Mitosis is not a key target of microtubule agents in patient tumors","volume":"8","author":"Komlodi-Pasztor","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1124\/molpharm.121.000297_bib28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1158\/1078-0432.CCR-11-0999","article-title":"Inhibitors targeting mitosis: tales of how great drugs against a promising target were brought down by a flawed rationale","volume":"18","author":"Komlodi-Pasztor","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1124\/molpharm.121.000297_bib29","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41467-019-13689-y","article-title":"STING-dependent paracriny shapes apoptotic priming of breast tumors in response to anti-mitotic treatment","volume":"11","author":"Lohard","year":"2020","journal-title":"Nat Commun"},{"key":"10.1124\/molpharm.121.000297_bib30","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nature23449","article-title":"cGAS surveillance of micronuclei links genome instability to innate immunity","volume":"548","author":"Mackenzie","year":"2017","journal-title":"Nature"},{"key":"10.1124\/molpharm.121.000297_bib31","doi-asserted-by":"crossref","first-page":"10192","DOI":"10.1158\/0008-5472.CAN-10-2429","article-title":"Free tubulin modulates mitochondrial membrane potential in cancer cells","volume":"70","author":"Maldonado","year":"2010","journal-title":"Cancer Res"},{"key":"10.1124\/molpharm.121.000297_bib32","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0140-6736(20)31953-X","article-title":"Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial","volume":"396","author":"Mittendorf","year":"2020","journal-title":"Lancet"},{"key":"10.1124\/molpharm.121.000297_bib33","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1365-2443.2010.01426.x","article-title":"p62\/SQSTM1 cooperates with Parkin for perinuclear clustering of depolarized mitochondria","volume":"15","author":"Okatsu","year":"2010","journal-title":"Genes Cells"},{"key":"10.1124\/molpharm.121.000297_bib34","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/s41416-018-0076-z","article-title":"Vinorelbine, cyclophosphamide and 5-FU effects on the circulating and intratumoural landscape of immune cells improve anti-PD-L1 efficacy in preclinical models of breast cancer and lymphoma","volume":"118","author":"Orecchioni","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1124\/molpharm.121.000297_bib35","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1124\/jpet.104.074484","volume":"312","author":"Podolin","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/molpharm.121.000297_bib36","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1158\/1535-7163.MCT-12-1019","article-title":"TLR4 is a novel determinant of the response to paclitaxel in breast cancer","volume":"12","author":"Rajput","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"10.1124\/molpharm.121.000297_bib37","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3389\/fphys.2019.00671","article-title":"Tubulin-VDAC interaction: molecular basis for mitochondrial dysfunction in chemotherapy-induced peripheral neuropathy","volume":"10","author":"Rovini","year":"2019","journal-title":"Front Physiol"},{"key":"10.1124\/molpharm.121.000297_bib38","doi-asserted-by":"crossref","first-page":"86594","DOI":"10.18632\/oncotarget.13358","article-title":"Integrating mechanisms of response and resistance against the tubulin binding agent Eribulin in preclinical models of osteosarcoma","volume":"7","author":"Sampson","year":"2016","journal-title":"Oncotarget"},{"key":"10.1124\/molpharm.121.000297_bib39","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1128\/IAI.00999-10","article-title":"The N-ethyl-N-nitrosourea-induced Goldenticket mouse mutant reveals an essential function of Sting in the in vivo interferon response to Listeria monocytogenes and cyclic dinucleotides","volume":"79","author":"Sauer","year":"2011","journal-title":"Infect Immun"},{"key":"10.1124\/molpharm.121.000297_bib40","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S1470-2045(19)30689-8","article-title":"Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"21","author":"Schmid","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1124\/molpharm.121.000297_bib41","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41586-019-0998-5","article-title":"Cryo-EM structures of STING reveal its mechanism of activation by cyclic GMP-AMP","volume":"567","author":"Shang","year":"2019","journal-title":"Nature"},{"key":"10.1124\/molpharm.121.000297_bib42","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.tcb.2018.05.001","article-title":"Microtubule-targeting agents: strategies to hijack the cytoskeleton","volume":"28","author":"Steinmetz","year":"2018","journal-title":"Trends Cell Biol"},{"key":"10.1124\/molpharm.121.000297_bib43","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1158\/1078-0432.CCR-20-4726","article-title":"Eribulin plus pembrolizumab in patients with metastatic triple-negative breast cancer (ENHANCE 1): a phase 1b\/2 study","volume":"27","author":"Tolaney","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1124\/molpharm.121.000297_bib44","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.1158\/0008-5472.CAN-17-3480","article-title":"Paclitaxel reduces tumor growth by reprogramming tumor-associated macrophages to an M1- profile in a TLR4-dependent manner","volume":"78","author":"Wanderley","year":"2018","journal-title":"Cancer Res"},{"key":"10.1124\/molpharm.121.000297_bib45","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1073\/pnas.1621363114","article-title":"cGAS is essential for the antitumor effect of immune checkpoint blockade","volume":"114","author":"Wang","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/molpharm.121.000297_bib46","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nature14156","article-title":"Mitochondrial DNA stress primes the antiviral innate immune response","volume":"520","author":"West","year":"2015","journal-title":"Nature"},{"key":"10.1124\/molpharm.121.000297_bib47","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.cell.2014.11.036","article-title":"Apoptotic caspases suppress mtDNA-induced STING-mediated type I IFN production","volume":"159","author":"White","year":"2014","journal-title":"Cell"},{"key":"10.1124\/molpharm.121.000297_bib48","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.cell.2016.05.076","article-title":"Hexokinase is an innate immune receptor for the detection of bacterial peptidoglycan","volume":"166","author":"Wolf","year":"2016","journal-title":"Cell"},{"key":"10.1124\/molpharm.121.000297_bib49","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/s41590-020-0751-0","article-title":"Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy","volume":"21","author":"Yamazaki","year":"2020","journal-title":"Nat Immunol"},{"key":"10.1124\/molpharm.121.000297_bib50","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.cell.2019.05.035","article-title":"The cytoplasmic DNA sensor cGAS promotes mitotic cell death","volume":"178","author":"Zierhut","year":"2019","journal-title":"Cell"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X2401174X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X2401174X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/molpharm.121.000297","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T12:27:32Z","timestamp":1740745652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X2401174X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0026895X2401174X"],"URL":"https:\/\/doi.org\/10.1124\/molpharm.121.000297","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eribulin Activates the cGAS-STING Pathway via the Cytoplasmic Accumulation of Mitochondrial DNA","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/molpharm.121.000297","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by The Author(s)","name":"copyright","label":"Copyright"}]}}